BACKGROUND: Integrated healthcare delivery systems present unique opportunities for cancer survivorship research. The National Cancer Institute funds the Cancer Research Network (CRN) to leverage these capabilities for all types of cancer research, including survivorship. METHODS: The authors gathered information from a recent CRN funding application, Survivorship Interest Group materials, the CRN website, and published articles. CRN studies were selected to illustrate diverse topics and a variety of data-collection approaches. RESULTS: The 14 systems that participate in the CRN provide care for approximately 10.8 million individuals of all ages and racial/ethnic backgrounds, for whom approximately 38,000 new cancer diagnoses were made in 2005. CRN systems have the ability to use existing data and collect new data on patients, providers, and organizations through well established research centers staffed by independent scientists. Of the 45 funded and 2 pending CRN grant applications as of November 30, 2007, 21 include aspects related to cancer survivorship. These studies have examined clinical trial participation, patterns of care, age and racial/ethnic disparities, diffusion of clinical trial findings, treatment outcomes, surveillance, and end-of-life and palliative care. Breast, colorectal, lung, ovarian, and prostate cancers have been the focus of these studies. Results of these studies have been published widely in leading journals. CONCLUSIONS: Completed and ongoing CRN survivorship studies provide a strong foundation for future studies. Scientists from all institutional affiliations are welcome to approach the CRN with ideas and are encouraged to allow ample time to establish collaborative relationships and design rigorous studies.
BACKGROUND: Integrated healthcare delivery systems present unique opportunities for cancer survivorship research. The National Cancer Institute funds the Cancer Research Network (CRN) to leverage these capabilities for all types of cancer research, including survivorship. METHODS: The authors gathered information from a recent CRN funding application, Survivorship Interest Group materials, the CRN website, and published articles. CRN studies were selected to illustrate diverse topics and a variety of data-collection approaches. RESULTS: The 14 systems that participate in the CRN provide care for approximately 10.8 million individuals of all ages and racial/ethnic backgrounds, for whom approximately 38,000 new cancer diagnoses were made in 2005. CRN systems have the ability to use existing data and collect new data on patients, providers, and organizations through well established research centers staffed by independent scientists. Of the 45 funded and 2 pending CRN grant applications as of November 30, 2007, 21 include aspects related to cancer survivorship. These studies have examined clinical trial participation, patterns of care, age and racial/ethnic disparities, diffusion of clinical trial findings, treatment outcomes, surveillance, and end-of-life and palliative care. Breast, colorectal, lung, ovarian, and prostate cancers have been the focus of these studies. Results of these studies have been published widely in leading journals. CONCLUSIONS: Completed and ongoing CRN survivorship studies provide a strong foundation for future studies. Scientists from all institutional affiliations are welcome to approach the CRN with ideas and are encouraged to allow ample time to establish collaborative relationships and design rigorous studies.
Authors: Jessica Chubak; Rebecca Ziebell; Robert T Greenlee; Stacey Honda; Mark C Hornbrook; Mara Epstein; Larissa Nekhlyudov; Pamala A Pawloski; Debra P Ritzwoller; Nirupa R Ghai; Heather Spencer Feigelson; Heather A Clancy; V Paul Doria-Rose; Lawrence H Kushi Journal: Cancer Causes Control Date: 2016-09-17 Impact factor: 2.506
Authors: Mara M Epstein; George Divine; Chun R Chao; Karen E Wells; Heather Spencer Feigelson; Delia Scholes; Douglas Roblin; Marianne Ulcickas Yood; Lawrence S Engel; Andrew Taylor; Joan Fortuny; Laurel A Habel; Christine C Johnson Journal: Int J Cancer Date: 2017-05-15 Impact factor: 7.396
Authors: Larissa Nekhlyudov; Sarah M Greene; Jessica Chubak; Borsika Rabin; Leah Tuzzio; Sharon Rolnick; Terry S Field Journal: J Cancer Surviv Date: 2012-12-14 Impact factor: 4.442
Authors: Erin J Aiello Bowles; Leah Tuzzio; Debra P Ritzwoller; Andrew E Williams; Tyler Ross; Edward H Wagner; Christine Neslund-Dudas; Andrea Altschuler; Virginia Quinn; Mark Hornbrook; Larissa Nekhlyudov Journal: Med Care Date: 2009-10 Impact factor: 2.983
Authors: Jessica Chubak; Leah Tuzzio; Clarissa Hsu; Catherine M Alfano; Borsika A Rabin; Mark C Hornbrook; Adele Spegman; Ann Von Worley; Andrew Williams; Larissa Nekhlyudov Journal: J Oncol Pract Date: 2012-01-24 Impact factor: 3.840
Authors: Ann M Geiger; Sharon M Castellino; Janet A Tooze; Andrea Altschuler; Stacy Month; Ann C Mertens; Larissa Nekhlyudov; Sarah M Greene Journal: J Adolesc Young Adult Oncol Date: 2013-06 Impact factor: 2.223
Authors: Erin J Aiello Bowles; Rod L Walker; Melissa L Anderson; Sascha Dublin; Paul K Crane; Eric B Larson Journal: PLoS One Date: 2017-06-20 Impact factor: 3.240
Authors: Scarlett Lin Gomez; Salma Shariff-Marco; Julie Von Behren; Marilyn L Kwan; Candyce H Kroenke; Theresa H M Keegan; Peggy Reynolds; Lawrence H Kushi Journal: BMC Cancer Date: 2015-10-14 Impact factor: 4.638